Skip to main content
Top
Published in: BMC Cancer 1/2018

Open Access 01-12-2018 | Research article

Improvements to the gastric cancer tumor-node-metastasis staging system based on computer-aided unsupervised clustering

Authors: Zhiqiong Wang, Mo Li, Zhen Xu, Yanlin Jiang, Huizi Gu, Ying Yu, Haitao Zhu, Hao Zhang, Ping Lu, Junchang Xin, Hong Xu, Caigang Liu

Published in: BMC Cancer | Issue 1/2018

Login to get access

Abstract

Background

The Union for International Cancer Control (UICC) tumor-node-metastasis (TNM) classification is a key gastric cancer prognosis system. This study aimed to create a new TNM system to provide a reference for the clinical diagnosis and treatment of gastric cancer.

Methods

A review of gastric cancer patients’ records was conducted in The First Hospital of China Medical University and the Liaoning Cancer Hospital and Institute. Based on patients’ prognoses data, computer-aided unsupervised clustering was performed for all possible TNM staging situations to create a new staging division system.

Results

The primary outcome measure was 5-year survival, analyzed according to TNM classifications. Computer-aided unsupervised clustering for all TNM staging situations was used to create TNM division criteria that were more consistent with clinical situations. Furthermore, unsupervised clustering for the number of lymph node metastasis in the N stage led to the formulation of a classification method that differs from the existing N stage criteria, and unsupervised clustering for tumor size provided an additional reference for prognosis estimates.

Conclusions

Finally, we developed a TNM staging system based on the computer-aided unsupervised clustering method; this system was more in line with clinical prognosis data when compared with the 7th edition of UICC gastric cancer TNM classification.
Literature
1.
go back to reference Chae S, Lee A, Lee JH. The effectiveness of the new (7th) UICC N classification in the prognosis evaluation of gastric cancer patients: a comparative study between the 5th/6th and 7th UICC N classification. Gastric Cancer. 2011;14:166–71.CrossRefPubMed Chae S, Lee A, Lee JH. The effectiveness of the new (7th) UICC N classification in the prognosis evaluation of gastric cancer patients: a comparative study between the 5th/6th and 7th UICC N classification. Gastric Cancer. 2011;14:166–71.CrossRefPubMed
2.
go back to reference Ramadori G, Triebel J. Nodal dissection for gastric cancer. N Engl J Med. 2008;359:2392. author reply 2393CrossRefPubMed Ramadori G, Triebel J. Nodal dissection for gastric cancer. N Engl J Med. 2008;359:2392. author reply 2393CrossRefPubMed
3.
go back to reference Santiago JM, Sasako M, Osorio J. TNM-7th edition 2009 (UICC/AJCC) and Japanese classification 2010 in gastric Cancer. Towards simplicity and standardisation in the management of gastric cancer. Cir Esp. 2011;89:275–81.CrossRefPubMed Santiago JM, Sasako M, Osorio J. TNM-7th edition 2009 (UICC/AJCC) and Japanese classification 2010 in gastric Cancer. Towards simplicity and standardisation in the management of gastric cancer. Cir Esp. 2011;89:275–81.CrossRefPubMed
4.
go back to reference Lu J, et al. Consideration of tumor size improves the accuracy of TNM predictions in patients with gastric cancer after curative gastrectomy. Surg Oncol. 2013;22:167–71.CrossRefPubMed Lu J, et al. Consideration of tumor size improves the accuracy of TNM predictions in patients with gastric cancer after curative gastrectomy. Surg Oncol. 2013;22:167–71.CrossRefPubMed
5.
6.
go back to reference GASTRIC (Global Advanced/Adjuvant Stomach Tumor Research International Collaboration) Group, Paoletti X, Oba K, Burzykowski T, Michiels S, Ohashi Y, Pignon JP, Rougier P, Sakamoto J, Sargent D, Sasako M, van Cutsem E, Buyse M. Benefit of adjuvant chemotherapy for resectable gastric cancer: a meta-analysis. JAMA. 2010;303(17):1729–37.CrossRef GASTRIC (Global Advanced/Adjuvant Stomach Tumor Research International Collaboration) Group, Paoletti X, Oba K, Burzykowski T, Michiels S, Ohashi Y, Pignon JP, Rougier P, Sakamoto J, Sargent D, Sasako M, van Cutsem E, Buyse M. Benefit of adjuvant chemotherapy for resectable gastric cancer: a meta-analysis. JAMA. 2010;303(17):1729–37.CrossRef
8.
go back to reference Brower V. Modified gastric cancer chemotherapy: more effective, less toxic. Lancet Oncol. 2015;16(16):e590.CrossRefPubMed Brower V. Modified gastric cancer chemotherapy: more effective, less toxic. Lancet Oncol. 2015;16(16):e590.CrossRefPubMed
9.
go back to reference Cristescu R, Lee J, Nebozhyn M, Kim KM, Ting JC, Wong SS, Liu J, Yue YG, Wang J, Yu K, Ye XS, Do IG, Liu S, Gong L, Fu J, Jin JG, Choi MG, Sohn TS, Lee JH, Bae JM, Kim ST, Park SH, Sohn I, Jung SH, Tan P, Chen R, Hardwick J, Kang WK, Ayers M, Hongyue D, Reinhard C, Loboda A, Kim S, Aggarwal A. Molecular analysis of gastric cancer identifies subtypes associated with distinct clinical outcomes. Nat Med. 2015;21(5):449–56.CrossRefPubMed Cristescu R, Lee J, Nebozhyn M, Kim KM, Ting JC, Wong SS, Liu J, Yue YG, Wang J, Yu K, Ye XS, Do IG, Liu S, Gong L, Fu J, Jin JG, Choi MG, Sohn TS, Lee JH, Bae JM, Kim ST, Park SH, Sohn I, Jung SH, Tan P, Chen R, Hardwick J, Kang WK, Ayers M, Hongyue D, Reinhard C, Loboda A, Kim S, Aggarwal A. Molecular analysis of gastric cancer identifies subtypes associated with distinct clinical outcomes. Nat Med. 2015;21(5):449–56.CrossRefPubMed
10.
go back to reference Shah MA, Ajani JA. Gastric cancer--an enigmatic and heterogeneous disease. Jama. 2010;303:1753–4.CrossRefPubMed Shah MA, Ajani JA. Gastric cancer--an enigmatic and heterogeneous disease. Jama. 2010;303:1753–4.CrossRefPubMed
11.
go back to reference Markar SR, Wiggins T, Ni M, Steyerberg EW, Van Lanschot JJ, Sasako M, Hanna GB. Assessment of the quality of surgery within randomised controlled trials for the treatment of gastro-oesophageal cancer: a systematic review. Lancet Oncol. 2015;16(1):e23–31.CrossRefPubMed Markar SR, Wiggins T, Ni M, Steyerberg EW, Van Lanschot JJ, Sasako M, Hanna GB. Assessment of the quality of surgery within randomised controlled trials for the treatment of gastro-oesophageal cancer: a systematic review. Lancet Oncol. 2015;16(1):e23–31.CrossRefPubMed
12.
go back to reference Nishida T, Doi T. Improving prognosis after surgery for gastric cancer. Lancet Oncol. 2014;15(12):1290–2.CrossRefPubMed Nishida T, Doi T. Improving prognosis after surgery for gastric cancer. Lancet Oncol. 2014;15(12):1290–2.CrossRefPubMed
13.
go back to reference Shen L, Shan YS, Hu HM, Price TJ, Sirohi B, Yeh KH, Yang YH, Sano T, Yang HK, Zhang X, Park SR, Fujii M, Kang YK, Chen LT. Management of gastric cancer in Asia: resource-stratified guidelines. Lancet Oncol. 2013;14(12):e535–47.CrossRefPubMed Shen L, Shan YS, Hu HM, Price TJ, Sirohi B, Yeh KH, Yang YH, Sano T, Yang HK, Zhang X, Park SR, Fujii M, Kang YK, Chen LT. Management of gastric cancer in Asia: resource-stratified guidelines. Lancet Oncol. 2013;14(12):e535–47.CrossRefPubMed
14.
go back to reference Zhang H, et al. Survival trends in gastric cancer patients of Northeast China. World J Gastroenterol. 2011;17:3257–62.PubMedPubMedCentral Zhang H, et al. Survival trends in gastric cancer patients of Northeast China. World J Gastroenterol. 2011;17:3257–62.PubMedPubMedCentral
15.
Metadata
Title
Improvements to the gastric cancer tumor-node-metastasis staging system based on computer-aided unsupervised clustering
Authors
Zhiqiong Wang
Mo Li
Zhen Xu
Yanlin Jiang
Huizi Gu
Ying Yu
Haitao Zhu
Hao Zhang
Ping Lu
Junchang Xin
Hong Xu
Caigang Liu
Publication date
01-12-2018
Publisher
BioMed Central
Published in
BMC Cancer / Issue 1/2018
Electronic ISSN: 1471-2407
DOI
https://doi.org/10.1186/s12885-018-4623-z

Other articles of this Issue 1/2018

BMC Cancer 1/2018 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine